Jacobs Levy Equity Management’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-43,761
| Closed | -$905K | – | 988 |
|
|
2024
Q1 | $905K | Hold |
43,761
| – | – | ﹤0.01% | 731 |
|
|
2023
Q4 | $1.01M | Hold |
43,761
| – | – | 0.01% | 718 |
|
|
2023
Q3 | $350K | Hold |
43,761
| – | – | ﹤0.01% | 863 |
|
|
2023
Q2 | $381K | Hold |
43,761
| – | – | ﹤0.01% | 852 |
|
|
2023
Q1 | $129K | Sell |
43,761
-49,671
| -53% | -$146K | ﹤0.01% | 928 |
|
|
2022
Q4 | $327K | Buy |
+93,432
| New | +$327K | ﹤0.01% | 850 |
|
|
2021
Q1 | – | Sell |
-28,285
| Closed | -$186K | – | 1053 |
|
|
2020
Q4 | $186K | Buy |
+28,285
| New | +$186K | ﹤0.01% | 966 |
|
|
2017
Q4 | – | Sell |
-3,350
| Closed | -$40K | – | 1009 |
|
|
2017
Q3 | $40K | Sell |
3,350
-11,297
| -77% | -$135K | ﹤0.01% | 934 |
|
|
2017
Q2 | $250K | Buy |
14,647
+3,300
| +29% | +$56.3K | 0.01% | 799 |
|
|
2017
Q1 | $195K | Buy |
+11,347
| New | +$195K | ﹤0.01% | 804 |
|